ORTIN GLOBAL LIMITED (ORTINGLOBE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

ORTINGLOBEUpdated 31 Aug 2026, 14:31

Ortin Global Limited

Market Cap

₹12.4Cr.

Current Price

₹15.2

High / Low

₹21.3/10.7

ROE-46.0%
ROCE-32.1%
Book Value₹1.52
Face Value₹10.0
Dividend Yield0.00%

About

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days103.7753.1390.35100.1582.4368.71174.90143.69208.05321.42279.12178.05
Inventory Days192.30148.72158.21152.21100.07117.80169.10136.29279.944.9234.760.00
Days Payable151.0924.82108.10143.09145.12155.80123.8261.88166.897.8769.52
Cash Conversion Cycle144.97177.04140.45109.2837.3830.70220.17218.10321.10318.47244.36178.05
Working Capital Days29.0016.2437.2941.4816.8211.24-87.22-109.10-43.19357.741,524.41730.00
ROCE %12.07%10.92%9.57%9.44%11.77%8.94%3.24%1.58%1.80%-40.58%-25.11%-32.14%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 14:31


Designed & Shipped by Harshit Bansal